Previous 10 | Next 10 |
Correvio Reports Full Year 2019 Financial Results Canada NewsWire VANCOUVER, March 30, 2020 ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected t...
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning th...
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH, CORV NEW YORK, NY / ACCESSWIRE / March 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following proposed mergers are fair to shareholde...
Penny Stocks To Watch This Week Fed Rate Cuts, emergency meetings, and more big developments over the weekend have triggered yet another big day of volatility. This has caused a massive breakdown in the market make-up for many blue-chip stocks right now. But that doesn’t mean opportun...
Vancouver-based ADVANZ PHARMA has agreed to acquire Correvio Pharma (NASDAQ: CORV ) for $0.42 per share or ~$28M. It will also pay off its outstanding debt of~$48M presenting a total transaction value of ~$76M exclusive of Correvio's current cash balance. More news on: Correvio Pharma Co...
NASDAQ: CORV TSX: CORV Acquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio Indebtedness ADVANZ PHARMA Intends to Pay for the Acquisition with Cash on Hand Provides ADVANZ PHARMA with an Im...
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China Canada NewsWire VANCOUVER and HONG KONG, March 10, 2020 NASDAQ: CORV TSX: CORV VANCOUVER and HONG KONG , March 10, 2020 /CNW/ - Correvio Pharma Corp. (NA...
Coronavirus Isn’t The Only Thing Driving Penny Stocks In a statement made on February 25, economist Mohamed El-Erian said to “resist automatically buying the dip after coronavirus-inspired stock-market sell-offs.” While broader markets jumped early on Tuesday morning, over...
Some financial outlets may tell you that all penny stocks should be avoided like the plague. But it really comes down to your personal strategy. No matter the investment, if you are well-educated, fully aware of the risks, and see an opportunity to capitalize, what’s there to avoid? One...
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that h...
News, Short Squeeze, Breakout and More Instantly...
Correvio Pharma Corp. Company Name:
CORV Stock Symbol:
NASDAQ Market:
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...
NASDAQ: CORV TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...